Dr Mak received her medical education at The University of Hong Kong. She completed her specialty training in year 2018 in Queen Mary Hospital Hong Kong as a gastroenterologist and hepatologist. She joined the academic faculty in year 2020 and obtained the degree of Doctor of Medicine in the field of clinical liver diseases in year 2021. Dr Mak’s research interests include clinical research of liver diseases, especially in the field of chronic viral hepatitis, fibrosis assessment and steatotic liver disease. She has published more than 160 peer-reviewed articles in reputable journals, with >80 being first-authored/ co-first/ corresponding authored articles, highlights including publications in Journal of Hepatology, Gut, Clinical Molecular Hepatology, and Hepatology. She is an Honorary Research Fellow of The Centre for Immunology and Infectious Diseases, Blizard Institute, Queen Mary University of London since Jan 2022 to conduct research in the field of HBV immunology, and received the Croucher Fellowship for post-doctoral research. Dr Mak is currently an associate editor for Clinical Molecular Hepatology, and editorial board member for Journal of Hepatology, Hepatology Communications and Journal of Clinical and Translational Hepatology.

Dr Mak has received numerous academic awards, highlight being The Emerging Leader Award by The European Association for the Study of Liver, which is a yearly award specifically dedicated to young fellows and will be given to 2-3 young scholars. Dr. Mak is the first Chinese woman to receive this award. She was Finalist for The Rising Star Award, EMMS International’s inaugural Global Women in Healthcare Awards in association with the Royal College of Physicians of Edinburgh in 2024.

Dr. Mak leads the viral hepatitis elimination efforts in Hong Kong, including the establishment of HCV program in persons under custody in correctional facilities, and steering committee to launch the mobile truck HBV screening project for the general population.